Literature DB >> 22707306

Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007.

Edgar P Simard1, Stacey Fedewa, Jiemen Ma, Rebecca Siegel, Ahmedin Jemal.   

Abstract

BACKGROUND: Despite substantial declines in cervical cancer mortality because of widespread screening, socioeconomic status (SES) disparities persist. The authors examined trends in cervical cancer mortality rates and the risk of late-stage diagnoses by SES.
METHODS: Using data from the National Vital Statistics System, trends in age-standardized mortality rates among women ages 25 to 64 years (1993-2007) by education level (≤12 years, 13-15 years, and ≥16 years) and race/ethnicity for non-Hispanic white (NHW) women and non-Hispanic black (NHB) women in 26 states were assessed using log-linear regression. Rate ratios (RRs) and 95% confidence intervals (CIs) were used to assess disparities between those with ≤12 years versus ≥16 years of education during 1993 to 1995 and 2005 to 2007. Avertable deaths were calculated by applying mortality rates from the most educated women to others in 48 states. Trends in the risk of late-stage diagnosis by race/ethnicity and insurance status were evaluated in the National Cancer Data Base.
RESULTS: Declines in mortality were steepest for those with the highest education levels (3.2% per year among NHW women and 6.8% per year among NHB women). Consequently, the education disparity widened between the periods 1993 to 1995 and 2005 to 2007 from 3.1 (95% CI, 2.4-3.9) to 4.4 (95% CI, 3.5-5.6) for NHW women and from 3.8 (95% CI, 2.0-7.0) to 5.6 (95% CI, 3.1-10.0) for NHB women. The risk of late-stage diagnosis increased for uninsured versus privately insured women over time. During 2007, 74% of cervical cancer deaths in the United States may have been averted by eliminating SES disparities.
CONCLUSIONS: SES disparities in cervical cancer mortality and the risk of late-stage diagnosis increased over time. Most deaths in 2007 may have been averted by eliminating SES disparities.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22707306     DOI: 10.1002/cncr.27606

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

Review 1.  Increasing Cervical Cancer Screening Among US Hispanics/Latinas: A Qualitative Systematic Review.

Authors:  Lilli Mann; Kristie L Foley; Amanda E Tanner; Christina J Sun; Scott D Rhodes
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

2.  Cervical cancer screening with AMIGAS: a cost-effectiveness analysis.

Authors:  David R Lairson; Yu-Chia Chang; Theresa L Byrd; Judith Lee Smith; Maria E Fernandez; Katherine M Wilson
Journal:  Am J Prev Med       Date:  2014-06       Impact factor: 5.043

3.  Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.

Authors:  Lisa P Spees; Wendy R Brewster; Mahesh A Varia; Morris Weinberger; Christopher Baggett; Xi Zhou; Victoria M Petermann; Stephanie B Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-07       Impact factor: 4.254

4.  An Ethical Justification for Expanding the Notion of Effectiveness in Vaccine Post-Market Monitoring: Insights from the HPV Vaccine in Canada.

Authors:  Ana Komparic; Maxwell J Smith; Alison Thompson
Journal:  Public Health Ethics       Date:  2015-01-29       Impact factor: 1.940

5.  Disparities in human papillomavirus vaccine awareness among U.S. parents of preadolescents and adolescents.

Authors:  Lauren E Wisk; Adelyn Allchin; Whitney P Witt
Journal:  Sex Transm Dis       Date:  2014-02       Impact factor: 2.830

6.  Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.

Authors:  Thomas Churilla; Brian Egleston; Yanqun Dong; Talha Shaikh; Colin Murphy; Gina Mantia-Smaldone; Christina Chu; Stephen Rubin; Penny Anderson
Journal:  Gynecol Oncol       Date:  2016-03-25       Impact factor: 5.482

7.  Applying operations research to optimize a novel population management system for cancer screening.

Authors:  Adrian H Zai; Seokjin Kim; Arnold Kamis; Ken Hung; Jeremiah G Ronquillo; Henry C Chueh; Steven J Atlas
Journal:  J Am Med Inform Assoc       Date:  2013-09-16       Impact factor: 4.497

8.  Quality of physician communication about human papillomavirus vaccine: findings from a national survey.

Authors:  Melissa B Gilkey; Teri L Malo; Parth D Shah; Megan E Hall; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-22       Impact factor: 4.254

9.  What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.

Authors:  Bill J Wright; Alison K Conlin; Heidi L Allen; Jennifer Tsui; Matthew J Carlson; Hsin Fang Li
Journal:  Cancer       Date:  2015-12-09       Impact factor: 6.860

10.  Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.

Authors:  Lisa P Spees; Stephanie B Wheeler; Mahesh Varia; Morris Weinberger; Christopher D Baggett; Xi Zhou; Victoria M Petermann; Wendy R Brewster
Journal:  Gynecol Oncol       Date:  2018-11-12       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.